Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem PK/PD in Tuberculosis
NCT01730664Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ertapenem in Tuberculosis (TB), sponsored by University Medical Center Groningen. Started Jan 2017; status: completed.
02
Drugs
ertapenem
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01730664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730664.